A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)

Middleton, G, Brown, S, Lowe, C et al. (17 more authors) (2013) A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO). European Journal of Cancer, 49 (16). 3507 - 3516. ISSN 0959-8049

Abstract

Metadata

Authors/Creators:
  • Middleton, G
  • Brown, S
  • Lowe, C
  • Maughan, T
  • Gwyther, S
  • Oliver, A
  • Richman, S
  • Blake, D
  • Napp, V
  • Marshall, H
  • Wadsley, J
  • Maisey, N
  • Chau, I
  • Hill, M
  • Gollins, S
  • Myint, S
  • Slater, S
  • Wagstaff, J
  • Bridgewater, J
  • Seymour, M
Keywords: Phase III; Colorectal; PICCOLO
Dates:
  • Published: November 2013
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Oncology and Clinical Research (Leeds) > Oncolocy/Cancer Research UK Clinical Centre (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 03 Nov 2014 11:58
Last Modified: 28 Jul 2015 15:13
Published Version: http://dx.doi.org/10.1016/j.ejca.2013.06.017
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.ejca.2013.06.017
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics